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ABSTRACT 
Quercetin is low molecular weight flavonoid having multiple neuropharmacological actions. Recently, its anticonvulsant effect was 
reported in rats using electrical kindling models. However, earlier cell culture studies have documented antagonistic action of 
quercetin on GABAA, GABAC and Glycine channels, which is contrary to recent findings. Hence, the present study aimed at 
characterizing the effects of quercetin administration in various experimental models of epilepsy. Dose-dependent effects of 
quercetin on maximal-electroshock seizure (MES) were determined. Further, the effective dose was tested in pentylenetetrazol-
induced seizures (PTZ), and strychnine-induced seizures to study the involvement of GABA and Glycinergic receptors. The results 
revealed a potent anticonvulsant effect of quercetin in MES induced seizures at a dose of 5 and 10 mg/kg. This effect was found to 
be retained in case of PTZ-induced convulsions and strychnine-induced convulsions (quercetin 10 mg/kg). The present finding 
warrants further substantiation along with their correlation to molecular mechanism of action. 
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INTRODUCTION:   
Natural products from folk remedies have contributed 
significantly in the discovery of modern drugs and can 
be an alternative source for antiepileptic drugs with 
novel structures and better safety and efficacy profiles. 
Quercetin reportedly has a wide range of biological 
activities. Recently quercetin (10 mg/kg) was reported 
to protect rats from kindling seizures after chronic 
administration of quercetin [40 mg/kg/day]. However an 
earlier work documented its proconvulsant potential by 
modulation of brain Hsp70 [70-kDal heat shock protein] 
in MES and NMDA-induced seizures
1
.  Further, it was 
reported that quercetin is an antagonist at GABAA and 
GABAC receptors, Human glycine 1 receptor. The IC50 
for brain glycine receptor is reported to be 10.7 µM and 
the mechanism is thought to be non-competitive in 
nature.The IC50 for GABAc and GABAA receptor was 
reported to be 4.4-4.8 µM. This evidence is contrary to 
the studies indicating anticonvulsant properties of 
quercetin. The aim of the present study was to 
systematically investigate the effect of quercetin 
administration on the incidence of convulsions in 
various experimental models of epilepsy
2,3
.  
MATERIALS AND METHODS: 
Animals Swiss Albino Mice (6-8 weeks) of either sex 
weighing about 18-20 g [Animal House of IPS 
Academy College of Pharmacy, India] were used for the 
study. All experimental procedures and protocols used 
in this study were approved by the Institutional Animal 
Ethics Committee (IAEC) (Protocol no. 
CPCSEA/82/2011). 
Drugs 
Quercetin and pentylenetetrazole (PTZ) were purchased 
from (Sigma-Aldrich Co, St. Louis, MO). Strychnine 
(STR) was generous gift from Alpa Laboratories 
(Indore, M.P., India). Phenytoin injection (Dilantin, 
Pfizer, India), diazepam injection (Calmpose, Ranbaxy, 
India) were purchased locally. Quercetin was dissolved 
in propylene glycol. All drugs were prepared each day 
as fresh solutions or suspensions and administered 
intraperitoneally (i.p.) in a volume of 0.01 ml/g body 
weight. 
Maximal electroshock convulsions 
Electroconvulsions were produced by an alternating 
current (0.2 s stimulus duration, 50 Hz) delivered via 
standard auricular electrodes by a Hugo Sachs generator 
(Rodent Shocker, Type 221, Freiburg, Germany). The 
criterion for the occurrence of seizure activity was the 
tonic hind limb extension
4
. 
Pentylenetetrazole (PTZ)-induced seizures 
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The PTZ-induced seizures in rodents are thought to be 
an experimental model of myoclonic convulsions in 
humans. Clonic convulsions were induced in mice by 
the s.c. administration of PTZ at the dose of 100 mg/kg. 
The clonic seizures were defined as clonus of the whole 
body lasting over 3 s with an accompanying loss of 
righting reflex
4
. 
Strychnine (STR)-induced convulsion              
Swiss albino mice (18-25g) were divided into different 
groups each containing five animals and treated with 
either  propylene glycol (5ml/kg) as control group, 
quercetin (1, 5, and 10 mg/kg, i.p.) as test group or 
glycine (750 mg/kg, i.p.) as standard group. Thirty 
minutes after drug/vehicle administration seizures were 
induced by intraperitoneal administration of 2 mg/kg 
strychnine nitrate. The time until occurrence of tonic 
extensor, convulsions and death was noted during 1h 
period
5
. 
Locomotor activity 
Separate groups of mice were treated with quercetin (10 
mg/kg, i.p.) or diazepam (2 mg/kg, i.p.) or respective 
control and were subjected to locomotor test session of 
10 min in an actophotometer
5
. 
Muscle relaxant activity 
Mice were selected for this test on their ability to remain 
on the revolving rod for at least 1 minute. The test 
compounds were administered intraperitoneally. Thirty 
minutes after intraperitoneal administration the mice 
were placed for 1 min on the rotating rod. The number 
of animals falling from the roller during this time is 
counted
5
. 
Statistical Analysis  
Data were expressed as the mean±SD. wherever 
required the data were analyzed with one-way Analysis 
of Variance (ANOVA) followed by Tukey’s multiple 
comparision test. P<0.05 was considered as significant.  
RESULTS AND DISCUSSION: 
Maximal Electroshock Convulsion 
A single maximal electroshock seizure produced an 
immediate tonic hind-limb extension of 5-10 s duration 
followed by clonic seizures, lasting up to 20 s. 
Following a maximal electroshock seizure, there was a 
significant (P < 0.01; ANOVA with post-hoc Tukey’s 
test). A single dose administration of Quercetin (1, 5 and 
10 mg/kg, i.p.) is significantly reduced hindlimb 
extension as compared to vehicle control after 4 h 
administration of Quercetin. On other hand 30 minutes 
after administration of Quercetin, only 10mg/kg is 
significantly reduced hindlimb extension. 
  
Table 1: Effects of Quercetin (1mg, 5mg, 10m/kg) after 30 minutes and 4 h on maximal electroshock-induced seizures 
Treatment Dose 
Duration of extensor in sec 
% Recovery 
After 30 min After 4hr 
Control 5ml/kg 15.80± 5.85 17.50±2.38 100 
Phenytoin 25mg/kg 3.67±1.16
a
 4.40±1.40
b
 100 
Quercetin 1mg/kg 13.40±3.36 7.60±0.89
b
 100 
Quercetin 5mg/kg 13.40±4.22 8.80±2.17
b
 100 
Quercetin 10mg/kg 3.75±0.96
a
 7,75±2.99
b
 100 
Values are expressed as mean ± S.D. (n=5) 
a
P<0.01, 
b
P<0.001 when compared with vehicle-control by one way 
analysis followed by Tukey’s test. 
Strychnine induced convulsion 
Quercetin at the dose of 10 mg/kg i.p. protected 100% 
and 80% of mice after 30 min and 4 h from tonic 
seizures respectively. The effect of glycine, 750 mg/kg 
(100% protection) 5mg and 10mg/kg 30 min. after 
administration of Quercetin significantly delayed the 
onset of the seizures. 
 
Table 2: Effect of the Quercetin on STR-induced tonic seizures in mice 
Treatment Dose 
Onset time of clonic convulsions % Recovery 
30 min 4 h 30 min 4h 
Control 5ml/kg 472.6±141.9 472.6±141.9 0 0 
Glycine 750  mg/kg 0.0±0.0
 c
 0.00 ±0.00
b
 100 100 
Quercetin 1mg/kg 170.6±167.7
a
 283.2±234.1 0 20 
Quercetin 5mg/kg 69.0±154.3
c
 292.2±183.7 80 20 
Quercetin 10mg/kg 48.20±107.8
c
 99.40±138.1
a
 100 80 
Values are expressed as mean ± S.D. (n=5). 
a
P<0.05,
b
P<0.01, 
c
P<0.001 when compared with vehicle-control by one 
way analysis followed by Tukey’s test. 
Pentylentetrazole induced convulsions 
Quercetin (10mg/kg) after 30 min. administration at the 
tested doses did not significantly influence the latency 
period of duration of convulsions, and mortality. 
Whereas, diazepam (10 mg/kg, i.p.) treated animals 
failed to show any signs of convulsions and protected all 
the mice from PTZ-induced convulsions. 
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Table 3: Effect of the Quercetin on PTZ-induced seizures in mice 
Treatment Dose Time of  Clonic Convulsions in sec % Recovery 
Control 5ml/kg 230.4±27.5 00 
Diazepam 25mg/kg 44.6±99.7
a
 80 
Quercetin 10mg/kg 102.4±140.2 60 
Values are expressed as mean ± S.D. (n=5). 
a
P<0.01, when compared with vehicle-control by one way analysis 
followed by Tukey’s test. 
Locomotor activity 
The average Actophotometer reading in the control 
group was after administration of Quercetin 10 mg/kg 
after 30 min did not reduced the locomotor activity. This 
shows that Quercetin did not have CNS depressant 
property.
 
Table 4: Effect of the Quercetin on locomotor activity in mice 
Treatment Dose Photocell count within 30 min. 
Control                                  5ml/kg 568.2±81.61 
Quercetin                           
 
10mg/kg 505.4±107.2
ns
 
Values are expressed as mean ± S.D. (n=5). 
ns
P>0.05, when compared with vehicle-control by one way analysis 
followed by Tukey’s test. 
Rota Rod Method 
Treatment with Quercetin (10 mg/kg), did not influence the rota rod performance in mice indicated the effects of these 
treatments were devoid of ataxic effects. 
Table 5: Effect of the Quercetin on muscle relaxant activity in mice 
Treatment Dose Rotating capacity of mice up to one min. 
Control                                  5ml/kg 60.00 ± 0.00 
Quercetin                           
 
10mg/kg 57.0 ± 2.8
 ns
 
Values are expressed as mean ± S.D. (n=5). 
ns
P>0.05, when compared with vehicle-control by one way analysis 
followed by Tukey’s test. 
CONCLUSION: 
The results revealed a potent anticonvulsant effect of 
quercetin in MES induced seizures at a dose of 5 and 10 
mg/kg and at higher dose 10 mg/kg STR-induced tonic 
seizures, PTZ-induced seizures.  This effect was found 
to be mediated via actions on the GABAergic and 
Glycinergic ion channels. The present finding warrants 
further substantiation along with their correlation to 
molecular mechanism of action. 
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